常州市存仁生物工程有限公司

AZD1480

AZD1480

Description of:AZD1480
AZD1480 suppresses the growth of human solid tumor xenografts harboring persistent Stat3 activity. [1] AZD1480 inhibited...
更多>>
TG101348

TG101348

Description of:TG101348
TG-101348 is a potent, highly selective and ATP- competitive JAK2 inhibitor with an IC50 of 3 nM for JAK2 and JAK2 V617...
更多>>
null

null

null...
更多>>
Momelotinib(CYT387)

Momelotinib(CYT387)

Description of:CYT387
CYT387 has significantly less activity against other kinases, including JAK3 (IC50=0.16 μM). CYT387 inhibits growth of...
更多>>
LY2784544(Gandotinib)

LY2784544(Gandotinib)

Description of:LY2784544
LY2784544 is a small molecule selective mutant JAK2 kinase inhibitor with an IC50 of 68 nM.
Theoretical analy...
更多>>
Ruxolitinib(INCB018424)鲁索替尼

Ruxolitinib(INCB018424)鲁索替尼

Description of:Ruxolitinib(INCB018424)鲁索替尼
INCB018424 (Ruxolitinib) is an orally bioavailable JAK inhibitor .(IC50 values for JAK1, JAK2 and JA...
更多>>
Tasocitinib(CP690550)

Tasocitinib(CP690550)

Description of:Tasocitinib(CP690550)
CP690550(Tasocitinib) treatment of murine factor-dependent cell Patersen-erythropoietin receptor (FDCP-Epo...
更多>>
总数: 27 页: 3 / 3 首页 ←上一页 下一页→ 末页